Language | English |
---|---|
Pages | 6939 |
Journal | Clinical Cancer Research |
Volume | 15 |
Issue number | 22 |
DOIs | |
Publication status | Published - 2009 |
Cite this
}
Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival. / Conway, C.; Mitra, A.; Jewell, R.; Randerson-Moor, J.; Lobo, S.; Nsengimana, J.; Edward, S.; Sanders, D. S.; Cook, M.; Powell, B.; Boon, A.; Elliott, F.; de Kort, F.; Knowles, M. A.; Bishop, D. T.; Newton-Bishop, J.
In: Clinical Cancer Research, Vol. 15, No. 22, 2009, p. 6939.Research output: Contribution to journal › Article
TY - JOUR
T1 - Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival
AU - Conway, C.
AU - Mitra, A.
AU - Jewell, R.
AU - Randerson-Moor, J.
AU - Lobo, S.
AU - Nsengimana, J.
AU - Edward, S.
AU - Sanders, D. S.
AU - Cook, M.
AU - Powell, B.
AU - Boon, A.
AU - Elliott, F.
AU - de Kort, F.
AU - Knowles, M. A.
AU - Bishop, D. T.
AU - Newton-Bishop, J.
PY - 2009
Y1 - 2009
U2 - 10.1158/1078-0432.CCR-09-1631
DO - 10.1158/1078-0432.CCR-09-1631
M3 - Article
VL - 15
SP - 6939
JO - Clinical Cancer Research
T2 - Clinical Cancer Research
JF - Clinical Cancer Research
SN - 1078-0432
IS - 22
ER -